Ciena formed three bases over a long period of time. The third, a flat base, launched one of the biggest moves by growth stocks in recent months.
The Federal Reserve may not be currently forecasting a recession, but sooner or later the U.S. economy’s fortunes will take a turn for the worse. And when that happens, home owners in Rochester, N.Y., can rest easy.
Artificial intelligence in housing won’t just eliminate Realtors. It could completely change the way we buy, sell and live.
Resistance is a precursor to many winning runs by superior growth stocks. Learning to recognize and use it is a fundamental investing skill.
Jeffrey Gundlach on Thursday struck a pessimistic tone, saying there was a 75% chance of a recession before the next election as he warned the corporate bond market was a crisis waiting to happen.
What’s left for the Federal Reserve to do at its rate-setting gathering next week now the U.S.’s main stock indexes are on the cusp of records again ?
This week shares of Tailored Brands were rocked, and rocked hard, as the specialty retailer of suits, business wear and sportswear fitted Wall Street with some harrowing news on the outlook for its business. Key retail business owned by Tailored Brands include Men's Wearhouse and Jos. Heading
Airline stocks have been all over the map this year, but Macquarie thinks that there’s more runway ahead for both one of the best performers in the group and one of the worst. Stock in (AAL) (AAL), another so-called legacy carrier, is firmly in the red. The shares have been hurt by lackluster earnings
Relatively cheap valuations and lower interest rates are causing investors to rush back into small-cap stocks and the ETFs that hold them.
The family of Chairman Emeritus Leonard A. Lauder, one of Estée Lauder’s sons, sold $392 million in shares of the upscale cosmetics firm on Sept 4.
On the stump, if there's one thing that both Republican and Democratic politicians have long claimed to support, it's lower drug prices. And when rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed…some fairly, and some not (as we'll see
DEEP DIVE Growth has beaten value in the stock market for many years. But if you are feeling uncertain about the market — the trade standoff, Brexit, the health of the European Union, the threat of a recession and years of unprecedented stimulus by central banks — it may be time for you to diversify
(Bloomberg) -- Terms of Trade is a daily newsletter that untangles a world embroiled in trade wars. Sign up here. The outlook on Portugal’s government bond rating was revised to positive from stable by S&P Global Ratings, reflecting its view that the country is better equipped to service its external
AveXis had a revolutionary gene therapy for babies with a deadly disease, and sold to Novartis for $8.7 billion. But in its hurry to get the drug approved, it made mistakes.
It was a week when everything that had been working stopped working, when losers were suddenly winners. Value and small-cap stocks gained, while momentum stocks fell.
With the market’s sudden lurch toward value stocks, some big names with lots of short interest could see a nice bump. We survey the field.
Volatility is elevated as the S&P 500 stalls near historic highs, while the software industry is oddly not participating in the recent rebound.
(Bloomberg) -- It wasn’t until late Thursday that the call Nasdaq executives were waiting for finally came through.WeWork’s Adam Neumann had picked Nasdaq over the more vaunted New York Stock Exchange for his hipster office company’s listing.With WeWork’s roadshow slated to kick off as early as next
S&P Global Ratings said on Friday that the Mexican government's 2020 economic growth forecast of 1.5% to 2.5% likely is too optimistic. The government's growth forecast is part of its 2020 budget blueprint unveiled last weekend, which also slightly loosened a primary surplus target as the government
Software stocks in the S&P 500 have fallen more than 4% since late July. Adobe results on Tuesday offer investors a chance to reassess the group.